Taking into account the fact that NFYA is the most important overall activator in the network, we can argue that under a repression of NFYA via ZHX2, the consequence will be a general inhibition of the transcriptional program, which may result for instance, in the progression of liver carcinoma. Here, NFYA is linked to hepatocellular carcinoma.